— Know what they know.
Not Investment Advice
Also trades as: XAGEW (NASDAQ) · $vol 0M

XAGE OTC

Longevity Health Holdings Inc.
1W: -20.9% 1M: -44.6% 3M: -52.5% YTD: -59.0% 1Y: -79.8% 3Y: -99.9% 5Y: -100.0%
$0.12
-0.01 (-10.12%)
 
Weekly Expected Move ±9.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 35 · $176556 mcap · 893389 float · 0.151% daily turnover · Short 30% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M +47.4% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$4M +47.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$3M -199.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$6M-$9M-$15M-$12M
Depreciation & Amort.$242K$243K$125K$197K
Stock-Based Comp.$247K$636K$668K$827K
Change in Working Capital$953K$2M-$3M$669K
Other Non-Cash Items$1M$2M$10M$6M
Operating Cash Flow-$1M-$4M-$8M-$4M
— Investing Activities —
Capital Expenditures-$7K-$7K-$30K$0
Acquisitions (Net)$0$0$0-$749K
Investment Purchases-$154M$0$0$0
Investment Sales$0$0$0$0
Other Investing$154M$0$0$0
Investing Cash Flow-$7K-$7K-$30K-$749K
— Financing Activities —
Net Debt Issuance$1M$3M-$3M-$218K
Stock Repurchased$0-$2K$0$0
Dividends Paid$0$0$0$0
Other Financing$68K$126K$14M-$86K
Financing Cash Flow$1M$4M$11M$2M
Net Change in Cash$11K$116K$3M-$3M
Cash End of Period$12K$128K$3M$157K
Free Cash Flow-$1M-$3M-$8M-$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms